Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Adecoagro AGRO 25. avr 2025 9.92 -15.14   
 Adeia ADEA 25. avr 2025 12.42 +1.14   
 Adial Pharmaceuticals ADIL 25. avr 2025 0.69 -4.20   
 Adicet Bio ACET 25. avr 2025 0.59 -4.62   
 Adient ADNT 25. avr 2025 12.57 -1.87   
 Aditxt ADTX 25. avr 2025 2.30 0.00   
 Adlai Nortye ANL 25. avr 2025 2.00 +5.00   
 ADMA Biologics ADMA 25. avr 2025 21.86 -2.10   
 Adobe ADBE 25. avr 2025 367.72 +1.89   
 ADS-TEC ADSE 25. avr 2025 13.99 +4.17   
 ADT ADT 25. avr 2025 7.85 +1.29   
 Adtalem Global Education ATGE 25. avr 2025 105.41 +0.92   
 ADTRAN ADTN 25. avr 2025 7.82 +1.43   
 Aduro Clean Technologies ADUR 25. avr 2025 4.31 -1.71   
 Advance Auto Parts AAP 25. avr 2025 32.88 -0.18   
 Advanced Biomed ADVB 25. avr 2025 1.81 0.00   
 Advanced Drainage Systems WMS 25. avr 2025 111.43 +0.27   
 Advanced Energy Industries AEIS 25. avr 2025 100.67 +3.87   
 Advanced Flower Capital AFCG 25. avr 2025 5.29 -1.31   
 Advanced Micro Devices AMD 25. avr 2025 96.64 +2.30   
 AdvanSix ASIX 25. avr 2025 21.10 -0.71   
 Advantage Solutions A ADV 25. avr 2025 1.33 +2.31   
 Advent AVK 25. avr 2025 11.09 +1.28   
 Advent Technologies A ADN 25. avr 2025 1.90 -3.55   
 Adverum Biotechnologies ADVM 25. avr 2025 2.91 -2.02   
 AdvisorShares Pure US Cannabis ETF MSOS 25. avr 2025 2.81 -0.71   
 Advisorshares Star Global Buy-Write ETF VEGA 25. avr 2025 42.77 +0.13   
 AECOM ACM 25. avr 2025 97.34 -0.32   
 Aegon N.V ADR AEG 25. avr 2025 6.45 +0.16   
 Aehr Test Systems AEHR 25. avr 2025 8.76 +0.81   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.